vs

Alexandria Real Estate Equities(ARE)与Astrana Health, Inc.(ASTH)财务数据对比。点击上方公司名可切换其他公司

Astrana Health, Inc.的季度营收约是Alexandria Real Estate Equities的1.4倍($950.5M vs $671.0M),Alexandria Real Estate Equities净利率更高(59.4% vs 0.7%,领先58.7%),Astrana Health, Inc.同比增速更快(42.9% vs -11.5%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs -6.4%)

Alexandria Real Estate Equities(NYSE:ARE)是标普500成分股中的城市办公类房地产投资信托,作为业内首创、运营经验最丰富的先行企业,专注于在顶级创新集群区域开发、运营生命科学、科技及农业科技协作型产业园区。截至2020年12月末,公司总市值达319亿美元,北美地区资产总面积达4970万平方英尺。

Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。

ARE vs ASTH — 直观对比

营收规模更大
ASTH
ASTH
是对方的1.4倍
ASTH
$950.5M
$671.0M
ARE
营收增速更快
ASTH
ASTH
高出54.4%
ASTH
42.9%
-11.5%
ARE
净利率更高
ARE
ARE
高出58.7%
ARE
59.4%
0.7%
ASTH
两年增速更快
ASTH
ASTH
近两年复合增速
ASTH
53.3%
-6.4%
ARE

损益表 — Q1 FY2026 vs Q4 FY2025

指标
ARE
ARE
ASTH
ASTH
营收
$671.0M
$950.5M
净利润
$398.4M
$6.6M
毛利率
营业利润率
1.9%
净利率
59.4%
0.7%
营收同比
-11.5%
42.9%
净利润同比
740.6%
184.4%
每股收益(稀释后)
$2.10
$0.12

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ARE
ARE
ASTH
ASTH
Q1 26
$671.0M
Q4 25
$754.4M
$950.5M
Q3 25
$751.9M
$956.0M
Q2 25
$762.0M
$654.8M
Q1 25
$758.2M
$620.4M
Q4 24
$788.9M
$665.2M
Q3 24
$791.6M
$478.7M
Q2 24
$766.7M
$486.3M
净利润
ARE
ARE
ASTH
ASTH
Q1 26
$398.4M
Q4 25
$-1.1B
$6.6M
Q3 25
$-232.8M
$373.0K
Q2 25
$-107.0M
$9.4M
Q1 25
$-8.9M
$6.7M
Q4 24
$-62.2M
$-7.8M
Q3 24
$167.9M
$16.1M
Q2 24
$46.7M
$19.2M
营业利润率
ARE
ARE
ASTH
ASTH
Q1 26
Q4 25
1.9%
Q3 25
2.0%
Q2 25
3.1%
Q1 25
3.3%
Q4 24
0.1%
Q3 24
5.9%
Q2 24
6.2%
净利率
ARE
ARE
ASTH
ASTH
Q1 26
59.4%
Q4 25
-143.3%
0.7%
Q3 25
-31.0%
0.0%
Q2 25
-14.0%
1.4%
Q1 25
-1.2%
1.1%
Q4 24
-7.9%
-1.2%
Q3 24
21.2%
3.4%
Q2 24
6.1%
3.9%
每股收益(稀释后)
ARE
ARE
ASTH
ASTH
Q1 26
$2.10
Q4 25
$-6.35
$0.12
Q3 25
$-1.38
$0.01
Q2 25
$-0.64
$0.19
Q1 25
$-0.07
$0.14
Q4 24
$-0.38
$-0.14
Q3 24
$0.96
$0.33
Q2 24
$0.25
$0.40

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ARE
ARE
ASTH
ASTH
现金及短期投资手头流动性
$418.7M
$429.5M
总债务越低越好
股东权益账面价值
$19.4B
$779.3M
总资产
$34.2B
$2.2B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
ARE
ARE
ASTH
ASTH
Q1 26
$418.7M
Q4 25
$549.1M
$429.5M
Q3 25
$579.5M
$463.4M
Q2 25
$520.5M
$342.1M
Q1 25
$476.4M
$260.9M
Q4 24
$552.1M
$290.8M
Q3 24
$562.6M
$350.3M
Q2 24
$561.0M
$327.7M
总债务
ARE
ARE
ASTH
ASTH
Q1 26
Q4 25
$12.4B
Q3 25
$13.6B
Q2 25
$13.3B
Q1 25
$13.1B
Q4 24
$12.2B
Q3 24
$12.7B
Q2 24
$12.4B
股东权益
ARE
ARE
ASTH
ASTH
Q1 26
$19.4B
Q4 25
$15.5B
$779.3M
Q3 25
$16.6B
$775.5M
Q2 25
$17.2B
$765.5M
Q1 25
$17.5B
$745.4M
Q4 24
$17.9B
$712.7M
Q3 24
$18.2B
$704.6M
Q2 24
$18.3B
$678.9M
总资产
ARE
ARE
ASTH
ASTH
Q1 26
$34.2B
Q4 25
$34.1B
$2.2B
Q3 25
$37.4B
$2.2B
Q2 25
$37.6B
$1.4B
Q1 25
$37.6B
$1.3B
Q4 24
$37.5B
$1.4B
Q3 24
$38.5B
$1.3B
Q2 24
$37.8B
$1.3B
负债/权益比
ARE
ARE
ASTH
ASTH
Q1 26
Q4 25
0.80×
Q3 25
0.82×
Q2 25
0.77×
Q1 25
0.75×
Q4 24
0.68×
Q3 24
0.70×
Q2 24
0.68×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ARE
ARE
ASTH
ASTH
经营现金流最新季度
$475.0M
$-2.9M
自由现金流经营现金流 - 资本支出
$-6.0M
自由现金流率自由现金流/营收
-0.6%
资本支出强度资本支出/营收
76.0%
0.3%
现金转化率经营现金流/净利润
1.19×
-0.44×
过去12个月自由现金流最近4个季度
$104.5M

8季度趋势,按日历期对齐

经营现金流
ARE
ARE
ASTH
ASTH
Q1 26
$475.0M
Q4 25
$312.4M
$-2.9M
Q3 25
$433.5M
$10.0M
Q2 25
$460.2M
$90.9M
Q1 25
$207.9M
$16.6M
Q4 24
$274.2M
$-10.9M
Q3 24
$477.4M
$34.0M
Q2 24
$411.8M
$23.2M
自由现金流
ARE
ARE
ASTH
ASTH
Q1 26
Q4 25
$-6.0M
Q3 25
$7.4M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
自由现金流率
ARE
ARE
ASTH
ASTH
Q1 26
Q4 25
-0.6%
Q3 25
0.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
资本支出强度
ARE
ARE
ASTH
ASTH
Q1 26
76.0%
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
现金转化率
ARE
ARE
ASTH
ASTH
Q1 26
1.19×
Q4 25
-0.44×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.84×
2.11×
Q2 24
8.82×
1.21×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ARE
ARE

Same properties$431.4M64%
Tenant recoveries$178.2M27%
Non-same properties$43.3M6%
Other$18.0M3%

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

相关对比